已鉴定出有前景的抗生素候选物。 - Suppr | 超能文献

Promising antibiotic candidate identified.

作者信息

Enserink M

出版信息

Science. 1999 Dec 17;286(5448):2245, 2247. doi: 10.1126/science.286.5448.2245.

DOI:10.1126/science.286.5448.2245

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Promising antibiotic candidate identified.已鉴定出有前景的抗生素候选物。

Science. 1999 Dec 17;286(5448):2245, 2247. doi: 10.1126/science.286.5448.2245.

2

Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.一种成孔肽抗生素对细胞壁前体脂II的利用。

Science. 1999 Dec 17;286(5448):2361-4. doi: 10.1126/science.286.5448.2361.

3

Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.通过溶液核磁共振映射靶向膜孔形成机制：乳酸链球菌肽Z与十二烷基硫酸钠胶束中脂磷壁酸的相互作用

Biochemistry. 2002 Jun 18;41(24):7670-6. doi: 10.1021/bi025679t.

4

The lantibiotic nisin, a special case or not?羊毛硫抗生素乳链菌肽，是个特例吗？

Biochim Biophys Acta. 1999 Dec 15;1462(1-2):223-34. doi: 10.1016/s0005-2736(99)00208-4.

5

The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci.万古霉素-乳链菌肽（1-12）杂合体恢复了对万古霉素耐药肠球菌的活性。

Biochemistry. 2008 Dec 2;47(48):12661-3. doi: 10.1021/bi801597b.

6

Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.乳链菌肽与肽聚糖前体脂 II 的特异性结合结合了孔形成和细胞壁生物合成抑制，从而具有强大的抗生素活性。

J Biol Chem. 2001 Jan 19;276(3):1772-9. doi: 10.1074/jbc.M006770200. Epub 2000 Oct 18.

7

Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin.羊毛硫抗生素尼生素抑制炭疽芽孢杆菌芽胞生长的机制。

ACS Chem Biol. 2011 Jul 15;6(7):744-52. doi: 10.1021/cb1004178. Epub 2011 May 5.

8

Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics.脂质结合肽聚糖前体在乳链菌肽、表皮菌素及其他羊毛硫抗生素形成孔道过程中的作用

Mol Microbiol. 1998 Oct;30(2):317-27. doi: 10.1046/j.1365-2958.1998.01065.x.

9

Dual antibacterial mechanisms of nisin Z against Gram-positive and Gram-negative bacteria.乳酸链球菌素Z对革兰氏阳性菌和革兰氏阴性菌的双重抗菌机制。

Int J Antimicrob Agents. 2005 Nov;26(5):396-402. doi: 10.1016/j.ijantimicag.2005.08.010. Epub 2005 Oct 13.

10

The generation of nisin variants with enhanced activity against specific gram-positive pathogens.生成对特定革兰氏阳性病原体具有增强活性的乳链菌肽变体。

Mol Microbiol. 2008 Jul;69(1):218-30. doi: 10.1111/j.1365-2958.2008.06279.x. Epub 2008 May 9.

引用本文的文献

1

Easy and rapid purification of highly active nisin.高效活性乳链菌肽的简易快速纯化

Int J Pept. 2011;2011:175145. doi: 10.1155/2011/175145. Epub 2011 Sep 18.

2

Prevalence, development, and molecular mechanisms of bacteriocin resistance in Campylobacter.弯曲杆菌中细菌素耐药性的流行、发展和分子机制。

Appl Environ Microbiol. 2011 Apr;77(7):2309-16. doi: 10.1128/AEM.02094-10. Epub 2011 Jan 28.

3

Insights into the mode of action of the two-peptide lantibiotic haloduracin.洞悉两肽类羊毛硫抗生素卤虫素的作用模式。

ACS Chem Biol. 2009 Oct 16;4(10):865-74. doi: 10.1021/cb900194x.